Month: September 2018

FSD Pharma to Expand into Jamaican Market and Introduce FSD Jamaica

CSE: HUGE OTC: FSDDF FRA: 0K9 TORONTO, Sept. 13, 2018 /CNW/ – FSD Pharma Inc. (“FSD” or the “Company”) (CSE: HUGE) (OTC: FSDDF) (FRA: 0K9) is pleased to announce that it intends to launch a strategic partnership into the Jamaican cannabis market as part of its plan to expand internationally. FSD has signed a Letter of Intent (“LOI”) effective September 10, 2018 with JJAMACANN Inc. (“JJAMACANN”) to form a joint venture operating as FSD Jamaica (“FSD Jamaica”). FSD Jamaica expects to partner locally with Nature’s Purest Limited (“NPL”), a Jamaican corporation with a cultivation license and existing operations in Jamaica.

Ehave at the forefront of Canada’s medical cannabis transformation

Canada’s cannabis industry is poised for explosive growth, as the country is set to legalize marijuana nationwide in the summer by July of 2018. By 2024, more than 450,000 Canadian patients will be prescribed medical cannabis, creating a market worth more than $1.3 billion, according to Health Canada estimates.

Canntab Therapeutics building cannabis delivery facility with FSD Pharma

Canntab Therapeutics Ltd (CSE:PILL) CEO Jeff Renwick and CFO Richard Goldstein tell Proactive Investor’s Christine Corrado the cannabis delivery manufacturing company is lining up its ducks ahead of the legalization of cannabis in Canada on October 17 this year – as it announced a profit sharing collaboration with medical pot producer FSD Pharma Inc.

FSD Pharma Breaks All-time Daily Volume Record and Continues to Make History

TORONTO, Sept. 12, 2018 /CNW/ – FSD Pharma Inc. (“FSD” or the “Company”) (CSE: HUGE) (OTC: FSDDF) (FRA: 0K9), is pleased to report that on September 11, 2018 the Company traded an aggregate total of exactly 213,761,823 shares. FSD traded 143,260,988 Class B subordinate voting shares on the Canadian Securities Exchange (“CSE”), 1,888,500 on AQC-Lit, 15,369,000 on AQC-Neo, 241,740 on CXC, 5,309,399 on CX2, 6,473,592 on CXD, 22,500 on Lynx, 24,750,500 on Omega and 16,445,604 on MatchNow. This is the largest total quantity of share volume traded by a CSE listed issuer by over 15.7% above the recorded all-time high of 184,718,114 also achieved by FSD on September 10, 2018, as confirmed by the CSE. This record is also  41%

Continue Reading “FSD Pharma Breaks All-time Daily Volume Record and Continues to Make History”

Deveron UAS Teams With A & L Canada to Improve Farm Productivity

Deveron UAS Corp., a drone data services company based out of Toronto, Ontario, has teamed up with A & L Canada Laboratories Inc., a research-driven technology company focused on sustainable development.

Khiron Raises $12.9 Million to Expand Colombia Medical Cannabis Operations

TORONTO, Sept. 12, 2018 /CNW/ – Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV:KHRN, OTCQB:KHRNF), a Canadian integrated medical cannabis company with its core operations in Colombia, is pleased to announce that it has closed today its previously announced best efforts short form prospectus offering of common shares (“Common Shares”), including the exercise in full of the over-allotment option (the “Offering”).

Canntab Therapeutics Launches Capital Markets Communications Strategy

Toronto, Ontario–(Newsfile Corp. – September 11, 2018) – Canntab Therapeutics Limited (CSE: PILL) (the “Company” or “Canntab”) is pleased to announce that, effective today, the Company will be increasing its level of engagement with shareholders and with potential retail and institutional investors. Accordingly, it has retained the services of Mackie Research Capital Corporation (“Mackie Research”) to act as financial advisor to the Company and the services of Hybrid Financial Limited (“Hybrid”) to assist the Company with Investor Relations by effectively communicating the Company’s message to an increasingly broad range of investment advisors across Canada.

FSD Pharma Issues 40,000,000 Stock Options to Director Dr. Raza Bokhari Conditional on NASDAQ listing

TORONTO, Sept. 11, 2018 /PRNewswire/ – FSD Pharma Inc. (“FSD Pharma” or the “Company”) (CSE: HUGE) (OTC: FSDDF) (FRA: 0K9) announces that pursuant to its Stock Option Plan, the Board approved the grant of 3,000,000 stock options for class B subordinate voting shares of the Company (the “Options”) on August 14, 2018 to Dr. Raza Bokhari following his appointment as a Director. The Options vest immediately and are exercisable at a price of $0.13 for a period of five years. The Company has also cancelled 15,000,000 stock options that had been previously issued at $0.05.

Khiron Life Sciences A De Facto Beneficiary of Aurora Cannabis – ICC Labs Deal

FSD Pharma Congratulates High Tide Ventures for Selection as Supplier to Ontario Cannabis Retail Corporation

TORONTO, Sept. 7, 2018 /CNW/ – FSD Pharma Inc. (“FSD Pharma” or “FSD”) (CSE: HUGE) (OTC: FSDDF) (FRA: 0K9) today congratulated High Tide Ventures Inc. (“High Tide”) for the selection of its wholly-owned subsidiary Famous Brandz Inc. (“Famous Brandz”) as an accessories supplier to the Ontario Cannabis Retail Corporation, operating as the Ontario Cannabis Store (“OCS”). Under the announcement by the OCS on September 5, 2018, Famous Brandz was one of ten accessories suppliers newly-selected to supply accessories to the adult-use market in the Province of Ontario.